lauric acid

lauric acid is a lipid of Fatty Acyls (FA) class. Lauric acid is associated with abnormalities such as Infection, Renal tubular disorder, Hypertensive disease, Obesity and Mycoses. The involved functions are known as Transcription, Genetic, Signal Transduction, Mutation, metaplastic cell transformation and Anabolism. Lauric acid often locates in Skin, Plasma membrane, Cytoplasmic matrix, Body tissue and Palmar surface. The associated genes with lauric acid are Gene Family, SLC33A1 gene, Homologous Gene, Open Reading Frames and P4HTM gene. The related lipids are Fatty Acids, Oleic Acids, Palmitates, Stearates and 9,11-linoleic acid.

Cross Reference

Introduction

To understand associated biological information of lauric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with lauric acid?

lauric acid is suspected in Renal tubular disorder, Hypertensive disease, Infection, Renal vascular disorder, Obesity, Mycoses and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with lauric acid

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Hyperlipidemias D006949 73 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Liver Diseases, Alcoholic D008108 13 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Lung Neoplasms D008175 171 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nephrosis, Lipoid D009402 2 associated lipids
Per page 10 20 50 | Total 33

PubChem Associated disorders and diseases

What pathways are associated with lauric acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with lauric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with lauric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with lauric acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with lauric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with lauric acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with lauric acid

Download all related citations
Per page 10 20 50 100 | Total 1837
Authors Title Published Journal PubMed Link
Mahdi ES et al. Effect of surfactant and surfactant blends on pseudoternary phase diagram behavior of newly synthesized palm kernel oil esters. 2011 Drug Des Devel Ther pmid:21792294
Hickey AJ and Byron PR Effect of a non-hygroscopic surfactant coating upon fluorescein absorption from the respiratory tract. 1987 Drug Des. Deliv. pmid:3509343
Funke AP et al. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen. 2003 Drug Dev Ind Pharm pmid:12906336
An NM et al. Development of a novel soft hydrogel for the transdermal delivery of testosterone. 2003 Drug Dev Ind Pharm pmid:12602497
Jung SY et al. Formulation and evaluation of ubidecarenone transdermal delivery systems. 2009 Drug Dev Ind Pharm pmid:19365779
Soler LI et al. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization. 2012 Drug Dev Ind Pharm pmid:22204649
Hossain MA et al. Effect of vehicle systems, pH and enhancers on the permeation of highly lipophilic aripiprazole from Carbopol 971P gel systems across human cadaver skin. 2012 Drug Dev Ind Pharm pmid:22067044
Chisty MN et al. In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes. 2002 Drug Dev Ind Pharm pmid:12476868
Abu-Huwaij R et al. Potential mucoadhesive dosage form of lidocaine hydrochloride: II. In vitro and in vivo evaluation. 2007 Drug Dev Ind Pharm pmid:17523008
Pattnaik S et al. Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling. 2011 Drug Dev Ind Pharm pmid:21446831
Cho YA and Gwak HS Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers. 2004 Drug Dev Ind Pharm pmid:15285328
Minn AL et al. Characterization of microsomal cytochrome P450-dependent monooxygenases in the rat olfactory mucosa. 2005 Drug Metab. Dispos. pmid:15879494
Pan J et al. Lipopolysaccharide-mediated modulation of cytochromes P450 in Stat1 null mice. 2003 Drug Metab. Dispos. pmid:12642464
Ozalp C et al. Bimolecular fluorescence complementation analysis of cytochrome p450 2c2, 2e1, and NADPH-cytochrome p450 reductase molecular interactions in living cells. 2005 Drug Metab. Dispos. pmid:15980100
Graham RA et al. In vivo and in vitro induction of cytochrome P450 enzymes in beagle dogs. 2002 Drug Metab. Dispos. pmid:12386126
Castle PJ et al. Human liver lauric acid hydroxylase activities. 1995 Drug Metab. Dispos. pmid:8654190
Yang YH et al. Heterologous expression of CYP2K1 and identification of the expressed protein (BV-CYP2K1) as lauric acid (omega-1)-hydroxylase and aflatoxin B1 exo-epoxidase. 2000 Drug Metab. Dispos. pmid:11038153
Poloyac SM et al. The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney. 2004 Drug Metab. Dispos. pmid:15205388
Buhler DR et al. The regiospecific hydroxylation of lauric acid by rainbow trout (Oncorhynchus mykiss) cytochrome P450s. 1997 Drug Metab. Dispos. pmid:9321521
Grillo MP and Lohr MT Covalent binding of phenylacetic acid to protein in incubations with freshly isolated rat hepatocytes. 2009 Drug Metab. Dispos. pmid:19196839
Grillo MP et al. Stereoselective flunoxaprofen-S-acyl-glutathione thioester formation mediated by acyl-CoA formation in rat hepatocytes. 2010 Drug Metab. Dispos. pmid:19786506
Li C et al. Covalent binding of 2-phenylpropionyl-S-acyl-CoA thioester to tissue proteins in vitro. 2003 Drug Metab. Dispos. pmid:12756204
Albro PW et al. In vitro metabolism of mono-2-ethylhexyl phthalate by microsomal enzymes. Similarity to omega- and (omega-1) oxidation of fatty acids. 1984 Nov-Dec Drug Metab. Dispos. pmid:6150824
Okita RT and Masters BS Effect of phenobarbital treatment and cytochrome P-450 inhibitors on the laurate omega- and (omega - 1)-hydroxylase activities of rat liver microsomes. 1980 May-Jun Drug Metab. Dispos. pmid:6104577
Dell HD et al. Etofenamate fatty acid asters. An example of a new route of drug metabolism. 1982 Jan-Feb Drug Metab. Dispos. pmid:6124384
Orton TC and Parker GL The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid. 1982 Mar-Apr Drug Metab. Dispos. pmid:6124394
Raza H and Levine WG Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate. 1986 Jan-Feb Drug Metab. Dispos. pmid:2868860
Levine WG and Raza H Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. 1988 May-Jun Drug Metab. Dispos. pmid:2900738
Yamaura Y et al. Predicting oxidation sites with order of occurrence among multiple sites for CYP4A-mediated reactions. 2011 Drug Metab. Pharmacokinet. pmid:21422671
Hayashi S et al. Essential role of singlet oxygen species in cytochrome P450-dependent substrate oxygenation by rat liver microsomes. 2005 Drug Metab. Pharmacokinet. pmid:15770071
Yasui H et al. Evidence for singlet oxygen involvement in rat and human cytochrome P450-dependent substrate oxidations. 2002 Drug Metab. Pharmacokinet. pmid:15618693
Yamazaki H et al. Activities of cytochrome p450 enzymes in liver and kidney microsomes from systemic carnitine deficiency mice with a gene mutation of carnitine/organic cation transporter. 2002 Drug Metab. Pharmacokinet. pmid:15618652
Parkinson A et al. On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice. 2006 Drug Metab. Rev. pmid:16684660
Imai Y et al. Structure-function relationships of cytochrome P-450 laurate (omega-1)-hydroxylase. 1989 Drug Metab. Rev. pmid:2680391
Noble MA et al. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains. 2007 Drug Metab. Rev. pmid:17786641
Miko M and Devínsky F Biochemical basis of cytotoxic activity of some new N'-oxides of N',N'-dimethylaminoalkylamides of dodecanoic acid. 1992 Drug Metabol Drug Interact pmid:1424644
Otomo S et al. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1). 1985 Drugs Exp Clin Res pmid:3880049
Goto J et al. A comparison of the effect of Lipo PGE1 and other related compounds on experimental peripheral arterial occlusive disease in rats. 1986 Drugs Exp Clin Res pmid:3816509
Wikström M [Nobel prize laureate in chemistry]. 1978 Duodecim pmid:729494
Cao J et al. Evaluation of the addition of various surfactant-suspended carbon nanotubes in MEEKC with an in situ-synthesized surfactant system. 2011 Electrophoresis pmid:21254135
Petersson P et al. Direct coupling of micellar electrokinetic chromatography to mass spectrometry using a volatile buffer system based on perfluorooctanoic acid and ammonia. 2003 Electrophoresis pmid:12658688
The Endocrine Society 2009 Laureate Awards. 2009 Endocr. Rev. pmid:19663077
The Endocrine Society Laureate Awards. 2009 Endocr. Rev. pmid:19663075
The Endocrine Society 2012 Laureate Awards. 2012 Endocr. Rev. pmid:23038815
The Endocrine Society Laureate Awards. 2012 Endocr. Rev. pmid:23038814
The Endocrine Society 2007 Laureate Awards. 2007 Endocr. Rev. pmid:17722366
The Endocrine Society Laureate Awards. 2007 Endocr. Rev. pmid:17722365
The Endocrine Society 2011 Laureate Awards. 2011 Endocr. Rev. pmid:21932463
The Endocrine Society Laureate Awards. 2011 Endocr. Rev. pmid:21932462
Lear PV et al. Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. 2010 Endocrinology pmid:20410201